VivoSeq
Other

Caesarean Delivery

0

Pipeline Programs

4

Active Trials

0

Companies Involved

Caesarean Delivery is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

8/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

12

clinical trials

Completed6 · 50%
Recruiting2 · 17%
Not yet recruiting2 · 17%
Terminated1 · 8%
Unknown status1 · 8%

Trial Activity

12 trials

Epinephrine Vs Norepinephrine Infusion During Caesarean Delivery
Not yet recruiting··N/A·NCT06512402·212 enrolled
Dexmedetomidine Versus Magnesium Sulphate for Caesarean Delivery
Unknown status··Phase 3·NCT03067896·78 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)